Statins may increase risk of diabetes by 46 percent
the ONA take:
The use of statins is associated with a 46% increase in the risk of developing diabetes, a new study published in the journal Diabetologia has shown.
For the study, researchers from the University of Eastern Finland and Kuopio University Hospital in Finland sought to investigate the effects of statin treatment on the risk of type 2 diabetes and blood sugar control in non-diabetic men that participated in the 6-year follow-up of the Metabolic Syndrome in Men (METSIM) study.
Among the 8,749 participants, 625 were diagnosed with new diabetes during the 5.9-year followw-up period.
Results showed that after adjusting for confounding factors, such as BMI, physical activity, alcohol intake, smoking, and beta-blocker and diuretic use, patients who took statins were 46% more likely to develop diabetes compared with those who were not treated with diabetes.
Researchers found that the high-dose simvastatin was associated with a 46% increased risk of developing diabetes compared with 28% increased risk for low-dose simvastatin. High-dose atorvastatin was associated with a 37% increased risk.
The use of statins is associated with a 46% increase in the risk of developing diabetes.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genetic Similarity to BRCA1/BRCA2 Mutations May Impact Treatment Options
- Evidenced-Based Radiation Treatment Tied to Cost Savings in Early Stage Breast Cancer
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|